PRJNA431487
Evaluate the sensitivity of CDK4/6 inhibitors in ESCC
Esophageal squamous cell carcinoma (ESCC) has a high mortality with no effective targeted therapies. We performed targeted deep sequencing combined with patient-derived cell line (PDC) and xenograft (PDX) models to explore potential therapeutic approaches and their biomarkers.